
HER2 Is Frequently Over-expressed in Ovarian Clear Cell Adenocarcinoma: Possible Novel Treatment Modality Using Recombinant Monoclonal Antibody against HER2, Trastuzumab
Masaki Fujimura, Noriyuki Katsumata, Hiroshi Tsuda, Naoko Uchi, Satomi Miyazaki, Takao Hidaka, Masatoshi Sakai, Shigeru SaitoVolume:
93
Année:
2002
Langue:
english
Pages:
8
DOI:
10.1111/j.1349-7006.2002.tb01231.x
Fichier:
PDF, 1.76 MB
english, 2002